1990
DOI: 10.1001/archopht.1990.01070090060040
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

Early Vitrectomy for Severe Vitreous Hemorrhage in Diabetic Retinopathy

Search citation statements

Order By: Relevance

Paper Sections

Select...
264
1
0
0

Citation Types

0
5
0
0

Year Published

Range
1991
1991
2026
2026

Publication Types

Select...
200
61
4

Relationship

0
265

Authors

Journals

citations

Cited by 265 publications

(5 citation statements)
references

References 1 publication

0
5
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…In a pilot randomized double-masked study, intravitreal ranibizumab or saline (control) was used 7 days prior to PPV in patients with TRD associated with PDR. At month 3, there was no difference in the progression of TRD prior to surgery, the duration of surgery, or its technical difficulty between the two groups, although ranibizumab reduced the extent of post-operative vitreous cavity hemorrhage, while the study was underpowered to reveal a difference in visual outcome [64].…”
Section: Intravitreal Anti-vegf Agents In the Management Of Vitreous Hemorrhage Due To Proliferative Diabetic Retinopathy
mentioning
confidence: 83%
“…Furthermore, during PPV, visible vitreoretinal traction is generally removed along with vitreous scaffolding, preventing subsequent TRD [62,63]. The Diabetic Retinopathy Vitrectomy Study (DRVS) supported that there is a benefit of early vitrectomy in patients with type 1 diabetes, exhibiting severe VH, while the majority (80%) of patients with type 2 diabetes and severe VH still require a vitrectomy to resolve the VH after 1 year [64]. The results of PPV with current techniques seem to be better than in DRVS.…”
Section: Intravitreal Anti-vegf Agents In the Management Of Vitreous Hemorrhage Due To Proliferative Diabetic Retinopathy
mentioning
confidence: 99%
See 1 more Smart Citation